Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1

Molecular Endocrinology

Volumn 16, Issue 3, 2002, Pages 515-528

  Holter, Elin ^a   Kotaja, Noora ^a   Mäkela, Sari ^b   Strauss, Leena ^c   Kietz, Silke ^d   Jänne, Olli A ^e   Gustafsson, Jan Åke ^a   Palvimo, Jorma J ^a   Treuter, Eckardt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; NUCLEAR RECEPTOR DAX 1; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENETIC TRANSCRIPTION; LIGAND BINDING; MALE GENITAL SYSTEM; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR INTRINSIC ACTIVITY; REPRODUCTION; TRANSCRIPTION INITIATION;

ANIMALIA; MAMMALIA;

EID: 0036192044     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.3.0804     Document Type: Article

References (66)

1. The nuclear receptor superfamily: The second decade
2. Orphan nuclear receptors: From gene to function
3. Ligand binding and nuclear receptor evolution
4. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes
5. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita
6. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis
7. Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA
8. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1
9. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors
10. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors
11. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita
12. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita
13. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression
14. Characterization of the mouse DAX-1 gene reveals evolutionary conservation of a unique amino-terminal motif and widespread expression in mouse tissue
15. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: Potential links in endocrine development
16. Differential patterns of expression of DAX-1 and steroidogenic factor-1 (SF-1) in the fetal rat testis
17. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function
18. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
19. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita
20. Fertility and infertility: Genetic contributions from the hypothalamic-pituitary-gonadal axis
21. Role of Ahch in gonadal development and game-togenesis
22. The role of DAX-1 in reproduction
23. Aromatase (Cyp19) expression is up-regulated by targeted disruption of Dax1
24. Steroid hormone receptors: Many actors in search of a plot
25. Minireview: Sex differentiation
26. Molecular basis of androgen receptor diseases
27. Androgen receptor transactivation domain and control of spermatogenesis
28. Androgen receptor defects: Historical, clinical, and molecular perspectives
29. Androgen receptor - An update of mechanisms of action in prostate cancer
30. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations
31. The coregulator exchange in transcriptional functions of nuclear receptors
32. Androgen-receptor-interacting nuclear proteins
33. Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita
34. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor
35. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity
36. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor
37. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells
38. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ER α and ER β
39. Hormonal and developmental regulation of DAX-1 expression in Sertoli cells
40. Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex
41. A role for estrogen receptor β in the regulation of growth of the ventral prostate
42. Estrogen receptors α and β in the normal, hyperplastic and carcinomatous human prostate
43. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation
44. Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split
45. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner
46. SMAD3 represses androgen receptor-mediated transcription
47. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor
48. Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6
49. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
50. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
51. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
52. Dax-1 as one of the target genes of Ad4BP/SF-1
53. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin
54. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation
55. Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation
56. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
57. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
58. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors
59. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2)
60. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function
61. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and nonprostate cell lines
62. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy
63. Frequent loss of estrogen receptor-β expression in prostate cancer
64. CREB-binding protein in androgen receptor-mediated signaling
65. Mutual transcriptional interference between RelA and androgen receptor
66. Localization of oestrogen receptors α and β in human testis